Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 119941
Published online Jun 27, 2026. doi: 10.4240/wjgs.119941
Published online Jun 27, 2026. doi: 10.4240/wjgs.119941
Table 2 Patient reported preoperative symptom between the two groups, n (%)
| Characteristic | ARMS (n = 14) | Double-dose PPI (n = 14) | P value |
| Preop symptoms | |||
| Belching | 5 (35.7) | 6 (42.9) | 0.699 |
| Reflux | 12 (85.7) | 11 (78.6) | 0.622 |
| Heartburn | 9 (64.3) | 10 (71.4) | 0.686 |
| Regurgitation | 8 (57.1) | 8 (57.1) | 1.000 |
| Dysphagia | 4 (28.6) | 3 (21.4) | 0.663 |
| Cough | 2 (14.3) | 3 (21.4) | 0.622 |
| Laryngitis | 8 (57.1) | 7 (50.0) | 0.705 |
| Dyspnea | 1 (7.1) | 2 (14.3) | 0.541 |
| Epigastric/chest pain | 7 (50.0) | 6 (42.9) | 0.705 |
| Water brash | 6 (42.9) | 5 (35.7) | 0.699 |
| Globus sensation | 7 (50.0) | 8 (57.1) | 0.705 |
| Nausea | 2 (14.3) | 3 (21.4) | 0.622 |
| Emesis | 1 (7.1) | 1 (7.1) | 1.000 |
| Nocturnal symptoms | 9 (64.3) | 10 (71.4) | 0.686 |
- Citation: Jiang WJ, Liu J, Liu YL, Tang MD, Sheng Y, Wang YT. Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients. World J Gastrointest Surg 2026; 18(6): 119941
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/119941.htm
- DOI: https://dx.doi.org/10.4240/wjgs.119941